Meanwhile, in the Caucasian population, 15% of NSCLC patients harbor driver EGFR mutations, that is, deletions in exon 19 (E746_A750del) or point mutation in exon 21 (L858R). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.